Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity.
- 29 August 1995
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (18) , 8200-8204
- https://doi.org/10.1073/pnas.92.18.8200
Abstract
In the tumor-bearing host, T cells invariably fail to induce a clinically significant antitumor immune response. Although model systems support the existence of tumor peptide antigens, the molecular interactions critical for antigen presentation by the tumor cell remain unresolved. Here, we demonstrate that human follicular lymphoma cells are highly inefficient at presenting alloantigen despite their strong expression of major histocompatibility complex and low-to-intermediate expression of some adhesion and B7 costimulatory molecules. Activation of follicular lymphoma cells via CD40 induces or up-regulates both adhesion and B7 costimulatory molecules essential to repair this defect. More importantly, once primed, alloreactive T cells efficiently recognize unstimulated follicular lymphoma cells. Thus, correction of defective tumor immunity requires not only expression of major histocompatibility complex but also sufficient expression of multiple adhesion and costimulatory molecules.Keywords
This publication has 28 references indexed in Scilit:
- Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice.The Journal of Experimental Medicine, 1995
- A new look for the 1990sNature, 1994
- The CD40 Antigen and its LigandAnnual Review of Immunology, 1994
- Tumor Antigens Recognized by T LymphocytesAnnual Review of Immunology, 1994
- B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance.The Journal of Experimental Medicine, 1993
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- Cancer vaccinesImmunology Today, 1993
- Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphomaNature, 1993
- Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.The Journal of Experimental Medicine, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993